Oral News and Research

RSS

Incyte announces results of Phase II clinical trial of oral JAK1 inhibitor in patients with RA

Incyte Corporation (Nasdaq: INCY) announced results from a 12-week, placebo-controlled, dose-escalationin involving 60 patients with active rheumatoid arthritis for its proprietary oral JAK1 inhibitor.

29 Oct 2013

Biogen Idec Q3 total revenues increase 32% to $1.8 billion

Biogen Idec Inc. today reported third quarter 2013 total revenues of $1.8 billion, an increase of 32% over the third quarter of 2012. Non-GAAP diluted EPS for the third quarter of 2013 were $2.35, an increase of 23% over the third quarter of 2012.

28 Oct 2013

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.

28 Oct 2013

Apremilast drug shows promise for Behcet's ulcers

Apremilast, an orally available small molecule modulating several inflammatory pathways, which is pending approval by the United States Food and Drug Administration, is showing promise in the treatment of mouth and genital ulcers in people with Behcet's syndrome, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.

28 Oct 2013

AAP National Conference to highlight innovative, successful to prevent and treat childhood obesity

A special session at the 2013 American Academy of Pediatrics (AAP) National Conference & Exhibition in Orlando will highlight innovative, successful ways pediatricians are working to prevent and treat childhood obesity.

25 Oct 2013

Endocrine Society issues Clinical Practice Guideline for polycystic ovary syndrome

The Endocrine Society today issued a Clinical Practice Guideline for the diagnosis and treatment of polycystic ovary syndrome, the most common hormone disorder in women of reproductive age and a leading cause of infertility.

25 Oct 2013

One painful experience at the dentist can lead to a lifetime of dental anxiety

One painful experience at the dentist in childhood can lead to a lifetime of dental anxiety and tooth decay. "Every week we see patients that are older, in their 30s, 40s and 50s who complain that at a much younger age such as in childhood, their previous dentist was rough, did not explain what was happening, carelessly drilled or poked and prodded and the memory is so fresh that they still feel anxiety as an adult," says Martin Hogan, DDS, Loyola University Health System.

24 Oct 2013

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary findings from researchers at the Perelman School of Medicine at the University of Pennsylvania being presented during an oral abstract session October 28 at the 15th World Conference on Lung Cancer.

24 Oct 2013

Case Western oral pain expert encourages people with persistent mouth pain to check for BMS

Oral pain that feels like a scalded mouth and can last for months has baffled dental researchers since the 1970s, when burning oral sensations were linked to mucosal, periodontal, and restorative disorders and mental or emotional causes.

24 Oct 2013

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

FDA grants Breakthrough Therapy designation to MK-5172/MK-8742 for chronic HCV infection

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has granted MK-5172/MK-8742 Breakthrough Therapy designation for treatment of chronic hepatitis C virus infection.

23 Oct 2013

BRCA1/2 mutations may alter endometrial, ovarian function

Scientists have detected significant differences in endometrial thickness and hormone levels in women with and without BRCA1/2 mutations that may play a role in cancer susceptibility or development.

22 Oct 2013

Pfizer to continue development of Remoxy Extended-Release Capsules CII

Pfizer Inc. announced today that, having achieved technical milestones related to manufacturing, it will continue the development program for Remoxy (oxycodone) Extended-Release Capsules CII.

22 Oct 2013

Sydney researchers plan to introduce rapid HIV and STI testing in pharmacies, dental surgeries

University of Sydney researchers are currently surveying community pharmacists and dentists to gauge their support to introduce rapid HIV and STI testing in pharmacies and dental surgeries, potentially increasing rates of early diagnosis.

22 Oct 2013

AstraZeneca begins selumetinib Phase 3 clinical trial in NSCLC patients

AstraZeneca today announced the first patient randomized in a Phase 3 clinical trial for selumetinib, an oral, potent, selective MEK inhibitor, being investigated as second-line therapy in patients with advanced or metastatic non-small-cell lung cancer whose tumors are KRAS mutation-positive.

22 Oct 2013

All Family Dentistry honored with Best of 2013 Fort Collins Award

All Family Dentistry is thrilled to accept the Best of 2013 Fort Collins Award from the Fort Collins Award Program. This honor is given to local businesses that provide superior service and outstanding benefits within their communities.

22 Oct 2013

Breast milk may protect babies from acquiring HIV infection, say researchers

A substance in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers has been identified for the first time by researchers at Duke Medicine.

22 Oct 2013

Univar signs agreement with Swati Spentose to become exclusive distributor of Lidocaine products

Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of Lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States.

22 Oct 2013

SPARC announces award recipients for Accelerating Science Award Program

The three award recipients for the Accelerating Science Award Program (ASAP) were announced today in Washington, DC at the Open Access Week kickoff event hosted by the Scholarly Publishing and Academic Resources Coalition (SPARC) and the World Bank.

22 Oct 2013

Exercise fights aging loss of smell

Regular exercise may help preserve the sense of smell in old age, a population-based study of olfactory loss reveals.

21 Oct 2013

Oral News and Research

Incyte announces results of Phase II clinical trial of oral JAK1 inhibitor in patients with RA

Biogen Idec Q3 total revenues increase 32% to $1.8 billion

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Apremilast drug shows promise for Behcet's ulcers

AAP National Conference to highlight innovative, successful to prevent and treat childhood obesity

Endocrine Society issues Clinical Practice Guideline for polycystic ovary syndrome

One painful experience at the dentist can lead to a lifetime of dental anxiety

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Case Western oral pain expert encourages people with persistent mouth pain to check for BMS

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

FDA grants Breakthrough Therapy designation to MK-5172/MK-8742 for chronic HCV infection

BRCA1/2 mutations may alter endometrial, ovarian function

Pfizer to continue development of Remoxy Extended-Release Capsules CII

Sydney researchers plan to introduce rapid HIV and STI testing in pharmacies, dental surgeries

AstraZeneca begins selumetinib Phase 3 clinical trial in NSCLC patients

All Family Dentistry honored with Best of 2013 Fort Collins Award

Breast milk may protect babies from acquiring HIV infection, say researchers

Univar signs agreement with Swati Spentose to become exclusive distributor of Lidocaine products

SPARC announces award recipients for Accelerating Science Award Program

Exercise fights aging loss of smell

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News